<html>
<head>PUBMED IDs for HSD5</head>
<body bgcolor='#C5F0F2'><h1>HSD5</h1><a href='https://pubmed.ncbi.nlm.nih.gov/15814298/'>Characterization of the basal promoter element of the human type 5 17beta-hydroxysteroid dehydrogenase gene.</a> April 9  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15850643/'>Expression of 3beta-hydroxysteroid dehydrogenase type 1, P450 aromatase, and 17beta-hydroxysteroid dehydrogenase types 1, 2, 5 and 7 mRNAs in human early and mid-gestation placentas.</a> April 27  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/17145895/'>17beta-hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer.</a> December 6  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/23647539/'>A challenge for medicinal chemistry by the 17β-hydroxysteroid dehydrogenase superfamily: an integrated biological function and inhibition study.</a> February 8  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23647513/'>Vitamin D analogue TX 527 down-regulates the NF-κB pathway and controls the proliferation of endothelial cells transformed by Kaposi sarcoma herpesvirus.</a> October 22  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24715382/'>Androgenic pathways in the progression of triple-negative breast carcinoma: a comparison between aggressive and non-aggressive subtypes.</a> November 13  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25817828/'>Local estrogen metabolism in epithelial ovarian cancer suggests novel targets for therapy.</a> July 21  2015<br></body></html>
